2-{[6-(3,5-dimethyl-1H-pyrazol-1-yl)-1,2,4,5-tetrazin-3-yl]amino}-2-(hydroxymethyl)propane-1,3-diol, 1g

ethyl 4-(4-cyanophenyl)-2-hydroxy-4-oxobut-2-enoate, 97%, 5g

beta-Ala-pNA�HBr, 99.0%, 1g

Ethyl 2,2-difluoro-3-hydroxy-3-methylbutanoate, 95%, 2.5g

Sodium pentafluoropropionate, 98.0%, 100g

4-(DIETHYLAMINO)CYCLOHEXANONE, 95.0%, 1g

(2S,4S)-4-FLUORO-PIPERIDINE-1,2-DICARBOXYLIC ACID 1-BENZYL ESTER, 95.0%, 50mg

2-Phenoxyethanol, min 99%, for synthesis, 250 ml, glass packaging

6-Chloro-2-(pyridin-2-yl)pyrimidin-4-amine, 95.0%, 1g

4-Bromodibenzo[b,d]furan-1-yl trifluoromethanesulfonate, 250mg

5-CHLORO-N-((2S,3R)-4-((3S,4R)-3,4-DIHYDROXYPYRROLIDIN-1-YL)-3-HYDROXY-4-OXO-1-PHENYLBUTAN-2-YL)-1H-INDOLE-2-CARBOXAMIDE, 95%, 5mg

1-Bromo-3,5-difluoro-2-(methoxymethoxy)benzene, 95%, 500mg

Tert-butyl (2R,4R)-2-cyano-4-hydroxypyrrolidine-1-carboxylate, 97%, 100mg